![Kenneth Hoberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Hoberman
Operationeel Directeur bij
STEMLINE THERAPEUTICS, INC.
Vermogen: 12 M $ op 31-05-2026
Profiel
Kenneth Hoberman is Vice Chairman at Lirum Therapeutics, Inc. since 2021.
Mr. Hoberman is Independent Director at TG Therapeutics, Inc. since 2014.
Mr. Hoberman is Independent Director at Nuvectis Pharma, Inc. since 2021.
Mr. Hoberman is Chief Operating Officer at Stemline Therapeutics, Inc. since 2013.
Mr. Hoberman was Vice President-Corporate & Business Development at Keryx Biopharmaceuticals, Inc. from 2004 to 2012.
Mr. Hoberman completed undergraduate studies at Boston University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-06-2026 | 279.653 ( 0,18% ) | 11 M $ | 31-05-2026 | |
| 11-06-2026 | 168.140 ( 0,63% ) | 2 M $ | 31-05-2026 |
Actieve functies van Kenneth Hoberman
| Bedrijven | Functie | Begin |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Operationeel Directeur | 01-01-2013 |
| TG THERAPEUTICS, INC. | Directeur/Bestuurslid | 15-12-2014 |
| NUVECTIS PHARMA, INC. | Directeur/Bestuurslid | 01-07-2021 |
| LIRUM THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-11-2021 |
Eerdere bekende functies van Kenneth Hoberman
| Bedrijven | Functie | Einde |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | 01-01-2012 |
Opleiding van Kenneth Hoberman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
31
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
